Waldmann TA - Search Results

1

Responses in refractory hairy cell leukemia to a recombinant immunotoxin.

Kreitman RJ, Wilson WH, Robbins D, Margulies I, Stetler-Stevenson M, Waldmann TA, Pastan I. Kreitman RJ, et al. Among authors: waldmann ta. Blood. 1999 Nov 15;94(10):3340-8. Blood. 1999. PMID: 10552943 Free article. Clinical Trial.

2

Mik-beta 1(Fv)-PE40, a recombinant immunotoxin cytotoxic toward cells bearing the beta-chain of the IL-2 receptor.

Kreitman RJ, Schneider WP, Queen C, Tsudo M, Fitzgerald DJ, Waldmann TA, Pastan I. Kreitman RJ, et al. Among authors: waldmann ta. J Immunol. 1992 Oct 15;149(8):2810-5. J Immunol. 1992. PMID: 1401913

3

The multichain interleukin-2 receptor: a target for immunotherapy.

Waldmann TA, Pastan IH, Gansow OA, Junghans RP. Waldmann TA, et al. Ann Intern Med. 1992 Jan 15;116(2):148-60. doi: 10.7326/0003-4819-116-2-148. Ann Intern Med. 1992. PMID: 1727619 Review.

4

Lymphokine receptor-directed therapy: a model for immune intervention in leukemia, autoimmunity, and immunodeficiency.

Waldmann TA. Waldmann TA. Clin Immunol Immunopathol. 1991 Nov;61(2 Pt 2):S37-46. doi: 10.1016/s0090-1229(05)80036-4. Clin Immunol Immunopathol. 1991. PMID: 1934612 Review.

5

IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes.

Lorberboum-Galski H, Garsia RJ, Gately M, Brown PS, Clark RE, Waldmann TA, Chaudhary VK, FitzGerald DJ, Pastan I. Lorberboum-Galski H, et al. Among authors: waldmann ta. J Biol Chem. 1990 Sep 25;265(27):16311-7. J Biol Chem. 1990. PMID: 1975810 Free article.

6

Selective elimination in vitro of alloresponsive T cells to human transplantation antigens by toxin or radionuclide conjugated anti-IL-2 receptor (Tac) monoclonal antibody.

Kozak RW, Fitzgerald DP, Atcher RW, Goldman CK, Nelson DL, Gansow OA, Pastan I, Waldmann TA. Kozak RW, et al. Among authors: waldmann ta. J Immunol. 1990 May 1;144(9):3417-23. J Immunol. 1990. PMID: 2139454

7

Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features.

Wright JJ, Wagner DK, Blaese RM, Hagengruber C, Waldmann TA, Fleisher TA. Wright JJ, et al. Among authors: waldmann ta. Blood. 1990 Nov 15;76(10):2046-51. Blood. 1990. PMID: 2146980 Free article.

8

IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells.

Kozak RW, Lorberboum-Galski H, Jones L, Puri RK, Willingham MC, Malek T, Fitzgerald DJ, Waldmann TA, Pastan I. Kozak RW, et al. Among authors: waldmann ta. J Immunol. 1990 Oct 15;145(8):2766-71. J Immunol. 1990. PMID: 2212661

9

The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.

Kreitman RJ, Chaudhary VK, Waldmann T, Willingham MC, FitzGerald DJ, Pastan I. Kreitman RJ, et al. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8291-5. doi: 10.1073/pnas.87.21.8291. Proc Natl Acad Sci U S A. 1990. PMID: 2236041 Free PMC article.

10

Kaposi's sarcoma in human T-cell leukemia virus type I-associated adult T-cell leukemia.

Greenberg SJ, Jaffe ES, Ehrlich GD, Korman NJ, Poiesz BJ, Waldmann TA. Greenberg SJ, et al. Among authors: waldmann ta. Blood. 1990 Sep 1;76(5):971-6. Blood. 1990. PMID: 2393719 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters